PMID- 36774389 OWN - NLM STAT- MEDLINE DCOM- 20230214 LR - 20230320 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 13 IP - 1 DP - 2023 Feb 11 TI - Mechanism of arterial injury exacerbated by hyperhomocysteinemia in spontaneously hypertensive rats. PG - 2482 LID - 10.1038/s41598-023-28731-9 [doi] LID - 2482 AB - Hypertension associated with hyperhomocysteinemia (HHcy) accounts for 75% of hypertension in China. HHcy plays a synergistic role with hypertension in vascular injury and significantly increases the incidence of cardiovascular and cerebrovascular diseases. The present study aimed to explore the molecular mechanism of HHcy-induced arterial injury in hypertension. Spontaneously hypertensive rats (SHR) were injected intraperitoneally with DL-homocysteine (Hcy) to construct the model of hypertension associated with HHcy (HHcy + SHR). Biological network was employed to identify the material basis of arterial injury in hypertension associated with HHcy. The prediction molecules in oxidative stress and inflammation pathways were experimentally verified by quantitative real-time polymerase chain reaction (qRT-PCR) and western blot (WB) analysis. The HHcy + SHR group significantly increased oxidative stress pathway molecules: nicotinamide adenine dinucleotide phosphate oxidase (Nox); inflammatory pathway molecules: vascular adhesion protein-1 (VAP-1), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-a); as well as inflammatory pathway regulatory factors: nuclear factor-kappa-gene binding (NF-kappaB) p65 and protein kinase B (Akt1). Among them, IL-6 was also significantly increased in the HHcy group. Both oxidative stress and inflammation contributed to the arterial injury of hypertension associated with HHcy, and inflammation mechanism might play a leading role in HHcy aggravating arterial injury, at least partially through the Akt1/NF-kappaB p65/IL-6 signaling pathway. CI - (c) 2023. The Author(s). FAU - Zhang, Lihua AU - Zhang L AD - Department of Medicine, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University, Jinan, China. FAU - Xu, Rui AU - Xu R AD - Department of Cardiology, Central Hospital Affiliated to Shandong First Medical University, Jinan, 250013, Shandong, People's Republic of China. xuruicn@hotmail.com. FAU - Ma, Xiaoshan AU - Ma X AD - Department of Medicine, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University, Jinan, China. FAU - Zhang, Xia AU - Zhang X AD - Laboratory Department, Jinan Maternity and Child Care Hospital, Jinan, China. FAU - Gong, Jun AU - Gong J AD - Department of Women Healthcare, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University, Jinan, China. FAU - Li, Zhongliang AU - Li Z AD - Department of Women Healthcare, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University, Jinan, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230211 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (NF-kappa B) RN - 0 (Interleukin-6) RN - 0LVT1QZ0BA (Homocysteine) SB - IM MH - Rats MH - Animals MH - Rats, Inbred SHR MH - NF-kappa B/metabolism MH - Interleukin-6/genetics MH - *Hyperhomocysteinemia/complications MH - *Vascular System Injuries/complications MH - Inflammation/metabolism MH - *Hypertension/complications MH - Homocysteine PMC - PMC9922276 COIS- The authors declare no competing interests. EDAT- 2023/02/12 06:00 MHDA- 2023/02/15 06:00 PMCR- 2023/02/11 CRDT- 2023/02/11 23:25 PHST- 2022/03/15 00:00 [received] PHST- 2023/01/24 00:00 [accepted] PHST- 2023/02/11 23:25 [entrez] PHST- 2023/02/12 06:00 [pubmed] PHST- 2023/02/15 06:00 [medline] PHST- 2023/02/11 00:00 [pmc-release] AID - 10.1038/s41598-023-28731-9 [pii] AID - 28731 [pii] AID - 10.1038/s41598-023-28731-9 [doi] PST - epublish SO - Sci Rep. 2023 Feb 11;13(1):2482. doi: 10.1038/s41598-023-28731-9.